Top

Published in:

01-12-2017 | Original Paper

Expression of microRNAs in tumors of the central nervous system in pediatric patients in México

Authors: Pilar Eguía-Aguilar, Lisette Gutiérrez-Castillo, Mario Pérezpeña-Díazconti, Jeanette García-Chéquer, Jorge García-Quintana, Fernando Chico-Ponce de León, Luis Gordillo-Domínguez, Samuel Torres-García, Francisco Arenas-Huertero

Published in: Child's Nervous System | Issue 12/2017

Abstract

Purpose

MicroRNAs were identified as molecules that participate in gene regulation; alterations in their expression characterize central nervous system (CNS). Information in pediatrics is scarce, so the objective of this work was to determine and then compare the patterns of expression of microRNAs in astrocytomas, ependymomas, and medulloblastomas, as well as in non-neoplastic brain.

Methods

Low-density arrays were utilized to evaluate 756 microRNAs in three samples of each type of tumor and non-neoplastic brain. The relative expression was calculated in order to identify the three microRNAs whose expression was modified notably. This was verified using RT-qPCR in more number of tumor samples.

Results

The microRNAs selected for testing were miR-100-5p, miR-195-5p, and miR-770-5p. A higher expression of miR-100-5p was observed in the astrocytomas and ependymomas compared to the medulloblastomas: on average 3.8 times (p < 0.05). MiR-770-5p was expressed less in medulloblastomas compared to astrocytomas four times (p = 0.0162). MiR-195-5p had a low expression in medulloblastomas compared to non-neoplastic cerebellum (p = 0.049). In all three tumor types, expression of miR-770-5p was lower than in non-neoplastic brain (p < 0.001).

Conclusions

These microRNAs may represent potential markers in these tumors.

Alrfaei B, Vemuganti R, Kuo J (2013) MicroRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models. PLoS One 8:1–13CrossRef

Apostolopoulos J, Sparrow R, McLeod J, Collier F, Darcy P, Slater H, Ngu C, Gregorio-King C, Kirkland M (2004) Identification and characterization of a novel family of mammalian ependymin-related proteins (MERPs) in hematopoietic, nonhematopoietic, and malignant tissues. DNA Cell Biol 20:625–635CrossRef

Braoudaki M, Lambrou G, Giannikou K, Papadodima S, Lykoudi A, Stefanaki K, Sfakianos G, Kolialexi A, Tzortzatou-Stathopoulou F, Tzetis M, Kitsiou-Tzeli S, Kanavakis E (2016) miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas. Tumor Biol. doi:10.1007/s13277-016-4903-7

Catania A, Maira F, Skarmoutsou E, D’amico F, Abounader R, Mazzarino C (2012) Insight into the role of micrornas in brain tumors. Inter J Oncol 40:605–624

Costa F, Bischof M, Vanin F, Lulla R, Wang M, Sredni T, Rajaram V, Bonaldo F, Wang D, Goldman S, Tomita T, Soares B (2011) Identification of MicroRNAs as potential prognostic markers in ependymoma. PLoS One 6:e25114CrossRefPubMedPubMedCentral

Dalmay T (2013) Mechanism of miRNA-mediated repression of mRNA translation. Essays Biochem 54:29–38CrossRefPubMed

Dubuc M, Mack S, Unterberger A, Northcott P, Taylor M (2012) The epigenetics of brain tumors. In Dumitrescu R, Verma M(eds). CancerEpigenetics. Humana Press Toronto, pp139–153

Ellison D (2010) Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease. Acta Neuropathol 120:305–316CrossRefPubMed

Ferretti E, De Smaele E, Po A, Marcotullio L, Tosi E, Espinola M, Di Rocco C, Riccardi R, Giangaspero F, Farcomeni A, Nofroni I, Laneve P, Gioia U, Caffarelli E, Bozzoni I, Screpanti I, Gulino A (2009) MicroRNA profiling in human medulloblastoma. Int J Cancer 124:568–577CrossRefPubMed

10.

Fineberg K, Kosik S, Davidson L (2009) MicroRNAs potentiate neural development. Neuron 64:303–309CrossRefPubMed

11.

Freije A, Castro-Vargas E, Fang Z, Horvath S, Cloughesy T, Liau L, Mischel P, Nelson S (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64:6503–6510CrossRefPubMed

12.

Gaur A, Holbeck S, Colburn N, Israel M (2011) Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro-Oncology 13:580–590CrossRefPubMedPubMedCentral

13.

Guo H, Ingolia N, Weissman J, Bartel D (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466:835–840CrossRefPubMedPubMedCentral

14.

He X, Liu Z, Peng Y, Yu C (2016) MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway. Biochem Biophys Res Commun 469:1041–1048CrossRefPubMed

15.

Hermansen S, Nielsen B, Aaberg-Jessen C, Kristensen B (2016) MiR-21 is linked to glioma angiogenesis: a co-localization study. J Histochem Cytochem 64:138–148CrossRefPubMed

16.

Ho C, Bar E, Giannini C, Marchionni L, Karajannis M, Zagzag D, Gutmann D, Charles G, Eberhart C, Rodriguez F (2013) MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. Neuro-Oncology 15:69–82CrossRefPubMed

17.

Hoffmann W (1994) Ependymins and their potential role in neuro-plasticity and regeneration: calcium-binding meningeal glycoproteins of the cerebrospinal fluid and extracellular matrix. Int J BioChemiPhysics 26:607–619CrossRef

18.

Hui W, Yuntao L, Lun L, WenSheng L, ChaoFeng L, HaiYong H, Yueyang B (2013) MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PLoS One 8:e54932CrossRefPubMedPubMedCentral

19.

Jia Z, Wang K, Zhang A, Wang G, Kang C, Han L, Pu P (2013) MiR-19a and miR-19b overexpression in gliomas. Pathol Oncol Res 13:847–853CrossRef

20.

Kaur K, Kakkar A, Kumar A, Mallick S, Julka P, Gupta D, Ashish Suri A, Suri V, Sharma M, Sarkar C (2015) Integrating molecular subclassification of medulloblastomas into routine clinical practice: a simplified approach. Brain Pathol. doi:10.1111/bpa.12293

21.

Krichevsky A, King K, Donahue C, Khrapko K, Kosik K (2003) A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9:1274–1281CrossRefPubMedPubMedCentral

22.

Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597–610PubMed

23.

Kunder R, Jalali R, Sridhar E, Moiyadi A, Goel N, Goel A, Gupta T, Krishnatry R, Kannan S, Kurkure P, Deopujari C, Shetty P, Biyani N, Korshunov A, Pfister S, Northcott P, Shirsat N (2013) A real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas. Neuro-Oncol 15:1644–1651CrossRefPubMedPubMedCentral

24.

Lakomy R, Sana J, Hankeova S, Fadrus P, Kren L, Lzicarova E, Svoboda M, Dolezelova H, Smrcka M, Vyzula R, Michalek J, Hajduch M, Slaby O (2011) MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci 102:2186–2190CrossRefPubMed

25.

Li R, Li X, Ning S, Ye J, Han L, Kang C, Li X (2014) Identification of a Core miRNA-pathway regulatory network in glioma by therapeutically targeting miR-181d, miR-21, miR-23b, b-catenin, CBP, and STAT3. PLoS One 9:1–13

26.

Liu F, Xiong Y, Zhao Y, Tao L, Zhang Z, Zhang H, Liu Y, Feng G, Li B, He L, Qin S, Yang Y (2013) Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray. Diagnostic Pathol 8:158–168

27.

Liu T, Papagiannakopoulos T, Puskar K, Qi S, Santiago F, Clay W, Lao K, Lee Y, Nelson F, Kornblum I, Doyle F, Petzold L, Shraiman B, Kosik S (2007) Detection of a microRNA signal in an in vivo expression set of mRNAs. PLoS One 2:804CrossRef

28.

Liu W, Gong Y, Chao T, Peng X, Yuan J, Ma Z, Jia G, Zhao J (2009) Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas. Chin Med J 20:2405–2411

29.

Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A, Scheithauer B, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefPubMedPubMedCentral

30.

Low A, De Sauvage F (2010) Clinical experience with Hedgehog pathway inhibitors. J Clin Oncol 28:5321–5326CrossRefPubMed

31.

Mack C, Taylor D (2009) The genetic and epigenetic basis of ependymoma. Childs Nerv Syst 25:1195–1201CrossRefPubMed

32.

Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Meyer H, Reifenberger G (2009) Identification and functional characterization of miRNAs involved in the malignant progression of gliomas. Brain Pathol. doi:10.1111/j.1750-3639.2009.00328.x

33.

Miele E, Romana F, Arcella A, Begalli F, Garg N,Silvano M, Po A, Baldi C, Carissimo G, Antonelli M, Spinelli G, Capalbo C, Donofrio V, Morra I, Nozza P, Gulino A, Giangaspero F, Ferretti E (2014) High-throughput microRNA profiling of pediatric high-grade gliomas. Neuro-Oncol 16:228-40

34.

Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O, Sitbon E, Lithwick G, Elyakim E, Cholakh H, Gibori H, Spector Y, Bentwich Z, Barshack I, Rosenfeld N (2009) MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 19:375–383CrossRefPubMedPubMedCentral

35.

Negrini M, Maira G, Croce C, Farace M (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351–1358CrossRefPubMed

36.

Pfaffl M (2001) A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res 29:e45CrossRefPubMedPubMedCentral

37.

Qu S, Yao Y, Shang C, Xue Y, Ma J, Li Z, Liu Y (2012) MicroRNA-330 is an oncogenic factor in glioblastoma cells by regulating SH3GL2 gene. PLoS One 7:e46010

38.

Rao A, Santosh V, Somasundaram K (2010) Genome-wide expression profiling identifies deregulated miRNAs in malignant astro-cytoma. Mod Pathol 23:1404–1417CrossRefPubMed

39.

Schmidt R, Brysch W, Rother S, Schlingensiepen K (1995) Inhibition of memory consolidation after active avoidance conditioning by antisense intervention with ependymin gene expression. J Neurochem 65:1465–1471CrossRefPubMed

40.

Shashoua V (1991) Ependymin, a brain extracellular glycoprotein, and CNS plasticity. Ann N Y Acad Sci 627:94–114CrossRefPubMed

41.

Sintupisut N, Liu P, Yeang C (2013) An integrative characterization of recurrent molecular aberrations in glioblastoma genomes. Nucleic Acids Res 41:8803–8821CrossRefPubMedPubMedCentral

42.

Sokol N (2012) Small temporal RNAs in animal development. Curr Opin Genet Dev 22:368–373CrossRefPubMedPubMedCentral

43.

Son J, Jeong H, Park D, Gyoon S, Lee E, Lee J, Chung H (2017) miR-10a and miR-204 as a potential prognostic indicator in low-grade gliomas. Cancer Informat 16:1–6CrossRef

44.

Ujifuku K, Mitsutake N, Takakura S, Matsuse M, Saenko V, Suzuki K, Hayashi K, Matsuo T, Kamada K, Nagata I, Yamashita S (2010) MiR-195, miR-455-3p and miR-10a are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett 28:241–248CrossRef

45.

Venkataraman S, Birks K, Balakrishnan I, Alimova I, Harris S, Patel R, Handler H, Dubuc A, Taylor D, Foreman K, Vibhakar R (2013) MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma. J Biol Chem 288:1918–1928CrossRefPubMed

46.

Visani M, de Biase D, Marucci G, Cerasoli S, Nigrisoli E, Bacchi M, Albani F, Baruzzi A, Pession A (2014) Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. Mol Oncol 8:417–430 Erratum in: MolOncol 2015;9:334CrossRefPubMed

47.

Wang X, Xin Z, Xu Y, Ma Y (2015) Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma. Tumor Biol. doi:10.1007/s13277-015-4455-2

48.

Wang X, Zhang H, Zhang A, Han L, Wang K, Liu R, Yang S, Pu P, Shen C, Kang C, Yu C (2012) Upregulation of miR-20a and miR-106b is involved in the acquisition of malignancy of pediatric brainstem gliomas. Oncol Reports 28:1293–1300CrossRef

49.

Wu W, Shi J, Hu G, Yu X, Lu H, Yang M, Liu B, Wu Z (2016) Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma. Tumor Biol 37:2313–2320CrossRef

50.

Xie T, Liu P, Chen L, Chen Z, Luo Y, Chen X, Feng Y, Luo X (2014) MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma. Clin Transl Oncol. doi:10.1007/s12094-014-1265-8

51.

Yan Y, Wang Q, Yan X, Zhang Y, Li W, Tang F, Li X, Yang P (2015) miR-10a controls glioma migration and invasion through regulating epithelial–mesenchymal transition via EphA8. FEBS Lett 589:756–765CrossRefPubMed

52.

Yilmaz S, Biray A, Dodurga Y, Dogan O, Oktar N, Gunduz C (2015) Downregulation of miR-195 via cyclosporin A in human glioblastoma cells. J Buon 20:1337–1340

53.

Zhang K, Han L, Chen L, Shi Z, Yang M, Ren Y (2014) Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas. Cancer Lett 342:139–149CrossRefPubMed

54.

Zhang Q, Xu H, Huang M, Ma L, Huang Q, Yao Q, Zhou H, Qu L (2012) MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion. Neuro-Oncology 14:278–287CrossRefPubMedPubMedCentral

55.

Zhang R, Luo H, Wang S, Chen Z, Hua L, Wang H, Chen W, Yuan Y, Zhou Y, Li D, Shen S, Jiang T, You Y, Liu N, Wang H (2015) MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells. J Neuro-Oncol 121:63–72CrossRef

Title: Expression of microRNAs in tumors of the central nervous system in pediatric patients in México
Authors: Pilar Eguía-Aguilar
Lisette Gutiérrez-Castillo
Mario Pérezpeña-Díazconti
Jeanette García-Chéquer
Jorge García-Quintana
Fernando Chico-Ponce de León
Luis Gordillo-Domínguez
Samuel Torres-García
Francisco Arenas-Huertero
Publication date: 01-12-2017
Publisher: Springer Berlin Heidelberg
Published in: Child's Nervous System / Issue 12/2017
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI: https://doi.org/10.1007/s00381-017-3569-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Expression of microRNAs in tumors of the central nervous system in pediatric patients in México

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2017

Presentation and symptom interval in children with central nervous system tumors. A single-center experience

Intramedullary placement of ventricular shunts: a review of using bone as a distal cerebrospinal absorption site in treating hydrocephalus

Case update on cranial osteopetrosis: which is the role of the neurosurgeon?

Treatment of abdominal pseudocysts and associated ventricuoperitoneal shunt failure

Malignant transformation of a conservatively managed incidental childhood cerebral mass lesion: controversy regarding management paradigm

Cognitive performance change of pediatric patients after conducting frontal transcortical approach to treat lateral ventricular tumor